The effect of esketamine in patients with treatment‐resistant depression with and without comorbid anxiety symptoms or disorder
Depression and Anxiety July 22, 2021 E. Daly, Ibrahim Turkoz, Giacomo Salvadore et al.
Comorbid anxiety is generally associated with poorer response to antidepressant treatment. This post hoc analysis explored the efficacy of esketamine plus an antidepressant in patients with treatment‐resistant depression (TRD) with or without comorbid anxiety.